Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects
Conditions: Tobacco Smoking; Tobacco Withdrawal; Nicotine Addiction; Nicotine Withdrawal; Nicotine Replacement Therapy Interventions: Drug: Bupropion Sponsors: National Institute of Respiratory Diseases, Mexico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials

Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
Conditions: Methamphetamine-dependence; Methamphetamine Abuse Interventions: Drug: extended-release naltrexone (XR-NTX); Drug: extended release bupropion (BUP-XL) tablets (BUP-XL); Drug: iPLB; Drug: oPLB Sponsors: National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Conditions: Major Depressive Disorder Interventions: Drug: AXS-05; Drug: Bupropion Sponsors: Axsome Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave ®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
Conditions: Obesity Interventions: Drug: Naltrexone-Bupropion (NB) Combination; Drug: Placebo Sponsors: Currax Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials

Voxelotor CYP and Transporter Cocktail Interaction Study
Condition:   Sickle Cell Disease Interventions:   Drug: Voxelotor;   Drug: Bupropion;   Drug: Repaglinide;   Drug: Flurbiprofen;   Drug: Omeprazole;   Drug: Midazolam;   Drug: Metformin;   Drug: Furosemide;   Drug: Rosuvastatin Sponsor:   Pfizer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials

Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
Conditions:   Addiction;   Opioid Use;   Substance Use Disorders;   Opioid Use Disorder Interventions:   Drug: Placebo;   Drug: Auvelity Sponsors:   Virginia Commonwealth University;   National Institute on Drug Abuse (NIDA) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2023 Category: Research Source Type: clinical trials